The role of early treatment of acute heart failure (AHF) is emphasized in current guidelines and recommendations. 1, 2 However, data on the role of pre-hospital emergency medical services (EMS) are scarce. 3 The aim of the present study was to describe the implementation and effects of EMS in AHF patients. Our second aim was to compare the characteristics and outcomes of patients arriving at emergency department (ED) by ambulance with those self-presenting.
All patients presenting to ED because of AHF between July 2012 and July 2013 were included. According to the use of EMS, patients were divided into EMS and self-presenting, non-EMS groups. Data were retrospectively collected from three university hospitals in the Helsinki metropolitan area. The study had institutional approval from Helsinki University Hospital. of CHF patients-received pre-hospital medication. In-hospital mortality was 5.9% in EMS patients receiving pre-hospital medication and 6.2% in patients not receiving any medication (P = 1.000). The length of stay (LOS), mean (SD), was 8.4 (9.4) days in the medicated patients and 7.3 (5.5) days in the non-medicated patients (P = 0.517).
In the EMS group, the initial pre-hospital vital signs and those upon presentation to the ED were: systolic blood pressure (SBP) 139.0 (32.1) mmHg and 140.6 (27.0) mmHg, heart rate (HR) 89. 92 .9 (6.6)%. The differences between initial HR and SpO 2 in EMS and non-EMS groups were statistically significant (P = 0.018 and P = 0.006). No statistically significant differences were observed in the vital signs on presentation, LOS, or in-hospital mortality between the EMS and non-EMS groups. Our main finding that only a minority of AHF patients used EMS, is in line with previous data showing that 22% of AHF patients used EMS. 3 Patients with worsening CHF tended to use EMS more often than those with de novo AHF. Compared with non-EMS patients, EMS patients were initially more unstable but improved before presentation to the ED. Hence, no difference was observed between non-EMS and EMS patients' vital signs in ED. In addition, although EMS patients had more co-morbidities, in-hospital mortality and LOS were similar in both groups. Surprisingly, only one-third of EMS patients received any medication. This may be an effect of the rather short transportation distances in the Helsinki metropolitan area. It has been suggested that it may be challenging for paramedics to diagnose AHF. 4 However, a higher proportion of de novo patients received pre-hospital medication compared with CHF patients in our study. in a previous study, in which only 6% of patients received it. 5 Although nitrate spray was commonly administered, nitrate infusion was administered to few patients. Contrary to a historical study, outcomes did not differ between EMS patients receiving pre-hospital medication and those that did not. 6 As expected, EMS patients were initially less stable than non-EMS patients. With regard to initial vital signs, EMS patients had higher HR and lower SpO 2 than non-EMS patients. However, there was no significant improvement in EMS patients' vital signs, from site to the ED presentation, except for HR. This may be caused by the infrequent administrations of medication. This finding is contrary to a previous study in which pre-hospital treatment improved vital signs. 5 That study included more unstable patients and the grade of improvement in vital signs seemed to depend on the baseline level.
Our study has several limitations. This was a retrospective study and the EMS cohort was relatively small. The data representing local policies of EMS use and pre-hospital medication may not be universally generalizable. In the Helsinki metropolitan area paramedic units do not have intravenous furosemide, and only ALS units and MICU offer the possibility of CPAP treatment and bronchodilators. The patients were initially rather stable and the results cannot be directly applied to more unstable patients. Some data is missing, especially on RR, which commonly goes unrecorded. The administration of supplementary oxygen was not recorded in EMS reports.
In conclusion, the use of EMS is rare among AHF patients. It depends on the severity of the patient's condition and is related to patient's medical history. The AHF patients' initial status on ED, LOS, and in-hospital mortality are independent of the arrival type. Thus, equal attention must be paid to the initial assessment of every AHF patient and the initiation of proper management on admission to ED. Whether more effective pre-hospital care would alter the clinical outcome remains to be proven in randomized clinical trials. However, according to our findings it may be challenging to perform prospective clinical trials in this limited population. 
